Accera

About:

Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases.

Website: https://accerapharma.com/

Twitter/X: accerainc

Top Investors: Wilmar International, Inventages Venture Capital Investment Inc., POSCO BioVentures, Bloodstone Ventures

Description:

Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases. It offers Ketasyn, a molecule for Alzheimer's, Parkinson's, and age-associated memory impairment. It was founded in 2001 and is headquartered in Broomfield, Colorado.

Total Funding Amount:

$196M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Broomfield, Colorado, United States

Founded Date:

2001-01-01

Contact Email:

info(AT)accerapharma.com

Founders:

Mark Heiman, Samuel Henderson, Steve Orndorff

Number of Employees:

51-100

Last Funding Date:

2018-10-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai